Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
<1m ago EIB EUROPEAN INVESTMENT BANK : Vladislav Goranov, new Governor for Bulgaria
<1m ago CHYRONHEGO : Partners With Fraunhofer IIS to Market and Develop GoalRef
<1m ago EVRAZ HIGHVELD STEEL AND VANADIUM : - 24 November 2014: Group Unaudited Results for the Nine Months Ended 30 September 2014
<1m ago EIB EUROPEAN INVESTMENT BANK : Janis Reirs, new Governor for Latvia
<1m ago EIB EUROPEAN INVESTMENT BANK : Maris Lauri, new Governor for Estonia
<1m ago PPHL PACIFIC PLYWOOD : CHANGE OF COMPANY SECRETARY, FINANCIAL CONTROLLER AND AUTHORIZED REPRESENTATIVE (in PDF)
<1m ago GENERAL MOTORS : Colorado and Canyon: Striving for the Perfect Body
<1m ago STARHUB : The 7th Annual Global CSR Summit & Awards 2015 to be held 19-20 March in Yogyakarta, Indonesia
<1m agoDJWal-Mart Adds Former American Airlines CEO Horton to Board
1m ago Stryker weighing bid for Smith & Nephew - Bloomberg
Latest news
Advertisement
Hot News 
SOLID STATE : Confident As First-Half Profit Nearly Triples
AVINGTRANS : Revises Down Expectations On Demand Drop, Contract Delays
RenaissanceRe to buy Platinum Underwriters for $1.9 billion
MOL GLOBAL : Block & Leviton LLP : Announces An Investigation Of MOL Global, Inc. Over Potential Violations Of The Federal Securities Laws After Its CFO Resigns
TLA WORLDWIDE : Says Real Madrid To Play In ICC Tournament In Australia
Most Read News
1d ago MANCHESTER UNITED : Red Devils Believed to Have Agreed Herrera Deal
1d agoDJYear-Old Messaging App Yik Yak Draws Big Valuation
1d ago PEARSON : chief promises a big push into China's education sector
1d ago VOLKSWAGEN : moves forward with dynamic young image
1d ago VOLVO : Being itself by being different gives Volvo Scandinavian edge
Most recommended articles
<1m ago Stryker weighing bid for Smith & Nephew - Bloomberg
3m ago Aviva falls on Friends Life merger plan doubts
4m ago Shell shuts Nigeria pipeline carrying Bonny Light crude
6m ago C$ gives back some of last week's gains
9m ago GOOGLE : EU lawmakers say not forging ideological war against Google
Dynamic quotes  
ON
| OFF